Proven
neurotechnology
built for the
real world
Control Bionics delivers objective, non-invasive neural-signal technology, proven in clinical environments, and built to scale across performance, rehabilitation, medical, research, and assistive communication.
Proven
neurotechnology
built for the
real world
Control Bionics delivers objective, non-invasive neural-signal technology, proven in clinical environments, and built to scale across performance, rehabilitation, medical, research, and assistive communication.
Capability
From signal to actionable insight
The Control Bionics neural-signal platform captures physiological data with medical-grade precision and converts it into measurable, decision-ready outcomes. Built for deployment across clinical, research, and performance environments — and validated where it counts.
Signal acquisition and processing
Real-time analysis and validation
Clinical integration and reporting
Technology
The platform serves distinct markets with precision and measurable outcomes. One underlying technology - four applications.
A platform built for clinical deployment
Medical-grade signal processing meets real-world clinical environments. Designed for integration, validation, and measurable outcomes.
Non-invasive neural signal capture
Physiological data without surgical intervention or implantation. Validated for use in complex clinical environments.
Regulatory pathway established
Cleared for clinical use with ongoing validation across multiple applications — FDA, TGA, and CE registered.
Outcome-focused architecture
Platform designed to deliver decision-ready insights, not only raw data. Built to integrate into clinical and research workflows.
Evidence from clinical and research deployment
Control Bionics technology is validated through research, clinical trials, and real-world deployment across rehabilitation, performance, and research settings.
1,000s of users
Trusted by individuals, clinicians, and organisations across four markets
Government and privately funded
Approved for funding through Medicare, Medicaid, NDIS, and private insurance pathways.
100%
Non-invasive signal acquisition
3 Regulatory clearances
(FDA, TGA, CE)
Latest from our platform
Research, clinical validation and platform developments.
Medicare Approves Life-Changing Technology for People with Disabilities
The NeuroNode provides a new solution for those with ALS/MND, Cerebral Palsy and more. Milford, Ohio, October 26, 2018 -- Control Bionics’ NeuroNode, a revolutionary life-altering assistive technology product, is universally available for people with...
Ok Google – Everyone Can Say It Now!
Control Bionics will be launching a revolutionary wireless, wearable EMG device complete with hands-free, voice-free Google Assistant control for the disabled population at the Closing the Gap Conference. MILFORD, OHIO - Sept. 26, 2018 - Control Bionics announces the...
NeuroSwitch Featured at Florida Alliance for Assistive Services and Technology (FAAST)
CEO Peter Ford and NeuroSwitch user Michael Phillips, who has spinal muscular atrophy, recently attended the Florida Alliance for Assistive Services and Technology (FAAST) 20th anniversary event. In the photo below, Michael Phillips is controlling a...
NPR-affiliate WVXU Interviews James Schorey + Peter Ford
This week, James and Peter discussed the NeuroSwitch and ALS patients with reporter Ann Thompson on WVXU, Cincinnati's NPR affiliate. The Control Bionics offices are located in Milford, near Cincinnati, so we were excited to share our work and the history of the...
Select your path to neural-signal insights and outcomes
Explore how the platform integrates into clinical workflows and delivers decision-ready outcomes.
Learn more
Discover how researchers are using real-time neural data to power breakthrough studies.
LearnNDIS-registered provider
Control Bionics is a registered NDIS provider. Eligible participants can access our assistive communication devices and neurotechnology solutions through their NDIS plan.